Autologous SUPLEXA is under clinical development by Alloplex Biotherapeutics and currently in Phase I for Bladder Cancer.

Following a recent trial, doctors at The Christie Hospital are optimistic about the study of HMBD-001 in the treatment of ...

Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain ...

The surge in cases of cancer in the under-50s has made many of us worry, with bowel, breast and lung cancers among those ...

Most common cancer which can occur in patients with untreated bladder stone is squamous cell carcinoma. This pathol ...

After 12 months of treatment for bladder cancer, Norfolk farmer DAVID JONES has spoken about his journey through chemotherapy and surgery ...

The Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic bladder ...

PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.

EXCLUSIVE - Cruel bladder cancer may have found a determined new adversary after an experimental drug have proven to not only ...

The following is a summary of “Low-cost and label-free blue light cystoscopy through digital staining of white light ...

An East Lancashire man has been part of a clinical trial for a new experimental drug for the most common form of bladder cancer. The drug, which is a targeted chemotherapy, is specially designed to ...